Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

    Grants for cancer research projects using imaging and liquid biopsies to monitor therapy responses and resistance emergence in patients.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Institutes of Health

    Due Dates: February 5, 2027 (New) | March 5, 2027 (Resubmission) | June 5, 2027 (New) | July 5, 2027 (Resubmission) | October 5, 2027 (New) | November 5, 2027 (Resubmission) | January 7, 2028 (Closing date)

    Funding Amounts: $500,000 award ceiling; budgets below $500,000 in direct costs annually; up to 5 years

    Summary: NCI supports integrated imaging and liquid biopsy studies to monitor cancer therapy response and emerging treatment resistance.

    Key Information: Experimental imaging and liquid biopsy methods must already be developed and validated, or in final validation.


    Description

    The National Cancer Institute (NCI), part of NIH, supports R01 research projects integrating imaging and fluid-based tumor monitoring (liquid biopsy) during cancer therapy. The program seeks to determine how these modalities complement one another in assessing treatment success, failure, recurrence, and emerging resistance. Its long-term goal is more accurate monitoring through assay combinations that add clinically meaningful information to conventional clinical and pathologic assessments.

    The initiative promotes collaboration among imaging scientists, fluid-based assay developers, and clinical scientists. Studies may combine established liquid biopsy biomarkers with experimental imaging, or established imaging with experimental liquid biopsy biomarkers. Imaging means in vivo molecular or functional clinical imaging; liquid biopsy measures molecular or cellular indicators in body fluids. Tissue-based assessments may establish correlations with imaging and liquid biopsy findings. Clinical trials are optional.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.